Bristol-Myers Squibb Co

BMY

Company Profile

  • Business description

    Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

  • Contact

    Route 206 and Province Line Road
    Princeton
    New JerseyNJ08543
    USA

    T: +1 609 252-4621

    E: [email protected]

    https://www.bms.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    34,100

Stocks News & Analysis

stocks

10 best US blue-chip stocks to buy for the long term

The stocks of these high-quality companies with large market capitalisations look undervalued today.
personal-finance

US stock market outlook: tariffs are 2025's wild card

Macrodynamic tailwinds persist, but stocks are already priced to perfection. Will tariffs derail the market in 2025?
stocks

5 undervalued US stocks that crushed earnings

Names like Sony and GSK are still cheap despite impressive earnings beats for Q2 2024.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,611.7038.300.45%
CAC 407,910.4931.93-0.40%
DAX 4024,122.4086.290.36%
Dow JONES (US)41,860.44816.80-1.91%
FTSE 1008,786.465.340.06%
HKSE23,827.78146.300.62%
NASDAQ18,872.64270.07-1.41%
Nikkei 22537,298.98230.51-0.61%
NZX 50 Index12,653.1749.93-0.39%
S&P 5005,844.6195.85-1.61%
S&P/ASX 2008,386.8043.500.52%
SSE Composite Index3,387.577.100.21%

Market Movers